CJC-1295 vs. Ipamorelin
Head-to-head comparison based on the profiles in the PepCycle library.
| Attribute | CJC-1295 | Ipamorelin |
|---|---|---|
| Class | Growth Hormone Peptides | Growth Hormone Peptides |
| Description | A synthetic analog of growth hormone-releasing hormone (GHRH) with extended half-life due to Drug Affinity Complex (DAC) technology. | A selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin levels. |
| Dose in studies | 1-2 mg per week (with DAC) or 100 mcg 2-3x daily (no DAC) | 200-300 mcg 2-3x daily |
| Frequency | Weekly (with DAC) or 2-3x daily (no DAC) | 2-3x daily |
| Half-life | ~6-8 days (with DAC) | ~2-3 hours |
| Cycle length | 8-16 weeks on, 4-8 weeks off | 8-16 weeks on, 4-8 weeks off |
| Research level | 2/5 – Limited research | 2/5 – Limited research |
CJC-1295: full profile · Ipamorelin: full profile
Values from research literature – not medical advice.